This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Nubain (Nalbuphine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (7)
Reports by Reaction Type
Hyperpyrexia (2),
Leukoencephalopathy (2),
Vomiting (2),
Nausea (2),
Mucosal Inflammation (2),
Leukopenia (2),
Hypersensitivity (1),
Drug Ineffective (1),
Loss of Consciousness (1),
Screaming (1),
Migraine (1),
Drug Hypersensitivity (1)
Possible Nubain side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient: female
Reactions: Vomiting, Nausea
Drug(s) suspected as cause:
Neurontin
Dosage: unk
Codeine
Dosage: unk
Nubain
Dosage: unk
Possible Nubain side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03
Patient: female
Reactions: Vomiting, Nausea
Drug(s) suspected as cause:
Neurontin
Dosage: unk
Codeine
Dosage: unk
Nubain
Dosage: unk
Possible Nubain side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-26
Patient: female, weighing 72.6 kg (159.7 pounds)
Reactions: Incoherent, Burning Sensation, Screaming
Drug(s) suspected as cause:
Nubain
Possible Nubain side effects in 33 year old female
Reported by a consumer/non-health professional from United States on 2012-02-29
Patient: 33 year old female
Reactions: Migraine, Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Imitrex
Administration route: Oral
Start date: 1996-01-01
Nubain
Indication: Migraine
Demerol
Indication: Migraine
Imitrex
Dosage: 6mg as required
Indication: Migraine
Start date: 1993-01-01
Other drugs received by patient: Amitriptyline HCL; Topamax; Nortriptyline HCL
Possible Nubain side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-23
Patient: 10 year old female, weighing 49.6 kg (109.1 pounds)
Reactions: Mucosal Inflammation, Hyperpyrexia, Leukoencephalopathy, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Morphine
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-03
End date: 2011-10-05
Amoxicillin
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-02
End date: 2011-10-08
Methotrexate
Indication: Bone Sarcoma
End date: 2011-09-26
Ifosfamide
Indication: Bone Sarcoma
End date: 2011-09-01
Etoposide
Indication: Bone Sarcoma
End date: 2011-09-01
Nubain
Indication: Pain
Start date: 2011-09-28
End date: 2011-10-03
Amikacin
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-02
End date: 2011-10-08
Other drugs received by patient: Etoposide; Plitican; Zofran; Zofran; Zometa; Leucovorin Calcium; Uromitexan
Possible Nubain side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-16
Patient: 10 year old female, weighing 49.6 kg (109.1 pounds)
Reactions: Mucosal Inflammation, Hyperpyrexia, Leukoencephalopathy, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Morphine
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-03
End date: 2011-10-05
Etoposide
Indication: Bone Sarcoma
End date: 2011-09-01
Ifosfamide
Indication: Bone Sarcoma
End date: 2011-09-01
Nubain
Indication: Pain
Start date: 2011-09-28
End date: 2011-10-03
Amoxicillin
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-02
End date: 2011-10-08
Methotrexate
Indication: Bone Sarcoma
End date: 2011-09-26
Amikacin
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-02
End date: 2011-10-08
Other drugs received by patient: Leucovorin Calcium; Etoposide; Zometa; Zofran; Uromitexan; Plitican; Zofran
Possible Nubain side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-20
Patient: 54 year old male
Reactions: Hypersensitivity, Drug Hypersensitivity, Peripheral Arterial Occlusive Disease, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Dosage: 40 mg/0.8 ml
Indication: Psoriatic Arthropathy
Start date: 2009-01-06
Nubain
Dosage: unk
Indication: Pain
Start date: 2010-05-01
End date: 2010-05-01
Other drugs received by patient: Ramipril; Kapsovit; Milk Thistle; Aspirin; Aludrox; Colecalciferol; Ubidecarenone
|